0001127602-19-013815.txt : 20190401
0001127602-19-013815.hdr.sgml : 20190401
20190401164317
ACCESSION NUMBER: 0001127602-19-013815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190328
FILED AS OF DATE: 20190401
DATE AS OF CHANGE: 20190401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdel-Malek Aiman
CENTRAL INDEX KEY: 0001670040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 19721313
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 600 TECHNOLOGY PARK DRIVE, SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-03-28
0001145197
INSULET CORP
PODD
0001670040
Abdel-Malek Aiman
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
EVP & Chief Technology Officer
Common Stock
2019-03-28
4
F
0
4305
94.04
D
19687
D
This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
/s/ John W. Kapples, attorney-in-fact
2019-04-01
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC):
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints Shacey Petrovic, John W. Kapples, Wayde D.
McMillan and Keith Bilezerian, and any one of them acting singly, the
true and lawful attorneys-in-fact and agents, with full power of
substitution and resubstitution, for the undersigned and in the
undersigned's name, place and stead, in any and all capacities (until
revoked in writing) to execute for and on behalf of the undersigned, in any
any and all of the undersigned's capacities, any and all statements on
Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by Insulet Corporation (the ?Company?) in
accordance with Sections 16(a) of the Securities Exchange Act of 1934, as
amended (the ?Exchange Act?), and any and all regulations promulgated
thereunder, and to file the same, with all exhibits thereto, and
any other documents in connection therewith, with the Securities
and Exchange Commission, and with any other entity when and if such
is mandated by the Exchange Act or by the By-laws of the National
Association of Securities Dealers, granting unto said attorneys-in-fact
and agents full power and authority to do and perform each and every
act and thing requisite and necessary fully to all intents and
purposes as the undersigned might or could do in person thereby
ratifying and confirming all that said attorneys-in-fact and
agents, or their substitute or substitutes, may lawfully do or
cause to be done by virtue hereof.
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4
and 5 with respect to the undersigned?s holdings of and
transactions in securities issued by the Company, unless
earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this Power of Attorney has been
signed as of March 26, 2019.
Signature: /s/ Aiman Abdel-Malek
Name: Aiman Abdel-Malek, PhD